Senior AI Lead for Oncology Clinical Development

AstraZeneca; Cambridge (MA); On-site; USD 144,000 - 216,000; Full time

Benefits offered by this job

Equity-based awards

Short-term incentive bonuses

Health/dental/vision coverage

Retirement programs

Job summary

AstraZeneca in Cambridge, MA is seeking a technical lead to advance AI for clinical development in oncology. You will shape strategy, lead high‑impact AI projects, and collaborate with teams across biometrics, regulatory, and study design to integrate novel AI into clinical trials.

You will mentor peers, publish work at venues, and build external collaborations with academia and partners while advancing the late‑stage drug pipeline.

Qualifications

• PhD in a quantitative discipline with strong computational/biomedical focus.
• At least 2+ years’ work experience outside PhD with measurable impact.

Responsibilities

• Contribute to AI strategy and roadmap for Oncology clinical development.
• Serve as technical lead on high-stakes AI projects across cross-functional teams.
• Develop and validate novel AI solutions for clinical study design and decision-making.
• Establish external collaborations to access novel capabilities and advance the AI roadmap.
• Represent AstraZeneca at conferences and publish in ML and clinical AI venues.
• Mentor team members and share expertise.

Skills

ML fundamentals

Foundation models

Biology domain knowledge

Software development

Collaboration

Education

PhD in quantitative discipline

2+ years work experience post-PhD

Tools

AI frameworks

Computational biology tools

Job description

AstraZeneca in Cambridge, MA is seeking a technical lead to advance AI for clinical development in oncology. You will shape strategy, lead high‑impact AI projects, and collaborate with teams across biometrics, regulatory, and study design to integrate novel AI into clinical trials.

You will mentor peers, publish work at venues, and build external collaborations with academia and partners while advancing the late‑stage drug pipeline.